Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer

PURPOSE: To determine the activity and toxicities of low dose leucovorin (LV) plus fluorouracil (5-FU) regimen, combined with oxaliplatin every two weeks (modified FOLFOX 4), as a first-line therapy for patients with metastatic colorectal cancer. MATERIALS AND METHODS: Between March 2001 and August...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kwon, Hyuk-Chan, Kim, Kyoung Tae, Lee, Shin Ae, Park, Jong-Sung, Kim, Sung-Hyun, Kim, Jae-Seok, Kim, Hyo Jin
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2004
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2855099/
https://ncbi.nlm.nih.gov/pubmed/20396550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2004.36.2.115
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars